Covid-19 divides the biggest medtechs
Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.
Joint makers report pandemic pain
Sales of implants are set to fall sharply as non-urgent procedures are deferred.
